ViewSonic recently held a distributors' event highlighting four main display application scenarios. Notable products included anti-peep AI screens and foldable large-size exhibition...
AI research emerged in the 1940s and made breakthroughs in areas like expert systems, natural language processing, and machine learning from the 1960s to the 1980s. Essential milestones...
Whether the benefits of Generative AI (GenAI) can be expanded from infrastructure to platforms and break the current situation, where the market is dominated by a few companies like...
Intel, a tech giant already struggling in the AI race, has seen its recent operational performance falter and its market value plummet to a level startlingly close to that of OpenAI...
The relationship between Microsoft and the AI startup OpenAI may be getting complicated, as Microsoft has included OpenAI on its list of competitors in its annual report, alongside...
OpenAI, responding to questions from US lawmakers, said it's dedicated to making sure its powerful AI tools don't cause harm, and that employees have ways to raise concerns about...
At CyberLink's Q2 earnings call, Chairman and CEO Jau Huang outlined the company's strategy to integrate generative AI and AI PC technologies into its software suite. Huang acknowledged...
International watchdogs are intensifying their scrutiny of leading tech giants, collaborating to examine potential monopolistic behaviors and partnerships that may skew the market.
OpenAI has reportedly engaged in talks with Broadcom to develop chips that could compete with Nvidia for AI chips and HBM supply, according to The Information. This move...
Microsoft has announced its decision to forgo its observer seat on OpenAI's board, with Apple reportedly following suit. Despite these moves, concerns about market monopolization...
OpenAI has come up with a set of five levels to track its progress toward building artificial intelligence software capable of outperforming humans, the startup's latest effort to...
In May 2024, French pharmaceutical giant Sanofi announced a three-way collaboration with Formation Bio and OpenAI to develop AI software for drug research.
